Pharming (PHAR) Interest Expenses (2019 - 2025)
Pharming (PHAR) posted Interest Expenses of $17.9 million for Q4 2025, up 81.06% on a QoQ basis from $9.9 million in Q4 2024, and up 81.06% year-over-year from $9.9 million in Q4 2024.
Pharming (PHAR) Interest Expenses (2019 - 2025) Analysis & Trends
Pharming's Interest Expenses history runs 7 years deep, the most recent figure standing at $17.9 million for Q4 2025.
- Quarterly Interest Expenses rose 81.06% year-over-year to $17.9 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $17.9 million (up 46.71% YoY) and the FY2025 annual result came in at $9.7 million, up 25.8% from the prior year.
- Interest Expenses was $17.9 million for Q4 2025 at Pharming, up from $9.9 million in the prior quarter.
- Across five years, Interest Expenses topped out at $17.9 million in Q4 2025 and bottomed at -$2.9 million in Q3 2021.
- A 5-year average of $4.5 million and a median of $2.0 million in 2021 frame the typical range for Interest Expenses.
- Peak annual rise in Interest Expenses reached 557.65% in 2023, while the deepest fall reached 152.84% in 2023.
- Pharming's Interest Expenses stood at $1.6 million in 2021, then decreased by 13.7% to $1.4 million in 2022, then surged by 557.65% to $9.1 million in 2023, then climbed by 9.02% to $9.9 million in 2024, then jumped by 81.06% to $17.9 million in 2025.
- Business Quant data shows PHAR's Interest Expenses at $17.9 million in Q4 2025, $9.9 million in Q4 2024, and $2.3 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Pharming | 8.69 Bn | 8.64 Bn | 65.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.90 Mn |
| Dec 31, 2025 | 17.90 Mn |
| Dec 31, 2024 | 9.89 Mn |
| Dec 31, 2024 | 9.89 Mn |
| Sep 30, 2024 | 2.32 Mn |
| Sep 30, 2024 | 2.32 Mn |
| Dec 31, 2023 | 9.07 Mn |
| Dec 31, 2023 | 9.07 Mn |
| Sep 30, 2023 | -633,000.00 |
| Sep 30, 2023 | -633,000.00 |
| Jun 30, 2023 | 5.25 Mn |
| Jun 30, 2023 | 5.25 Mn |
| Dec 31, 2022 | 1.38 Mn |
| Dec 31, 2022 | 1.38 Mn |
| Sep 30, 2022 | 1.20 Mn |
| Sep 30, 2022 | 1.20 Mn |
| Dec 31, 2021 | 1.60 Mn |
| Dec 31, 2021 | 1.60 Mn |
| Sep 30, 2021 | -2.89 Mn |
| Sep 30, 2021 | -2.89 Mn |